Entyvio 108 mg/0.68 mL single-dose prefilled pen Images
Generic Name: vedolizumab
This medication has been identified as Entyvio 108 mg/0.68 mL single-dose prefilled pen. It is supplied by Takeda Pharmaceutical Company Limited.
Entyvio is used in the treatment of Ulcerative Colitis; Crohn's Disease, Maintenance; Crohn's Disease and belongs to the drug class selective immunosuppressants. There is no proven risk in humans during pregnancy. Entyvio 108 mg/0.68 mL single-dose prefilled pen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Entyvio
- Generic Name
- vedolizumab
- Strength
- 108 mg/0.68 mL single-dose prefilled pen
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Takeda Pharmaceutical Company Limited
- National Drug Code (NDC)
- 64764-0108
More about Entyvio (vedolizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (162)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.